Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Turk Hava Yollari A.s.

Start price
Target price
Perf. (%)
€72.50
18.09.24
€75.00
18.09.25
-
18.09.24

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Turk Telekomunikasyon As

Start price
Target price
Perf. (%)
€2.12
18.09.24
€2.00
18.09.25
-
18.09.24

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
D-wave Quantum Inc.

Start price
Target price
Perf. (%)
€0.86
18.09.24
€1.00
18.09.25
2.86%
18.09.24

Fair valuation
Small cyclical dependencies
Revenue growth >5% per year expected
EBIT growth >5% per year expected
buy
Kri-kri Milk Industry S.a.

Start price
Target price
Perf. (%)
€13.70
18.09.24
-
18.09.25
0.00%
18.09.24

buy
Intel Corp.

Start price
Target price
Perf. (%)
€8.60
17.09.24
€9.00
17.09.25
-8.14%
18.09.24

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
positive Cash Flow expected
buy
Bicycle Therapeutics Ltd.

Start price
Target price
Perf. (%)
€22.60
17.09.24
-
17.09.25
-2.65%
18.09.24

buy
Siyata Mobile Inc.

Start price
Target price
Perf. (%)
€1.03
16.09.24
-
16.09.25
-4.37%
18.09.24

Could be worthwhile Investment >10% per year
buy
Cliq Digital AG

Start price
Target price
Perf. (%)
€7.15
16.09.24
€8.00
16.09.25
-2.52%
18.09.24

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
buy
Cementir Holding N.v.

Start price
Target price
Perf. (%)
€9.31
16.09.24
€18.00
16.09.25
3.11%
18.09.24

Could be very worthwhile Investment >20% year
buy
Corebridge Financial Inc.

Start price
Target price
Perf. (%)
€24.80
16.09.24
€50.00
16.09.25
-0.78%
18.09.24

Could be very worthwhile Investment >20% year
buy
Mereo Biopharma Group Ltd.

Start price
Target price
Perf. (%)
€3.76
16.09.24
-
16.09.25
1.06%
18.09.24

Could be worthwhile Investment >10% per year
buy
Novo-nordisk As

Start price
Target price
Perf. (%)
€123.44
16.09.24
-
16.09.25
-3.66%
18.09.24

buy
Immatics N.v.

Start price
Target price
Perf. (%)
€11.58
16.09.24
€20.00
31.03.27
-5.27%
18.09.24

Could be very worthwhile Investment >20% year
buy
Viridian Therapeutics Inc.

Start price
Target price
Perf. (%)
€19.40
16.09.24
€25.00
31.01.27
0.00%
18.09.24

Could be very worthwhile Investment >20% year
buy
Mereo Biopharma Group Ltd.

Start price
Target price
Perf. (%)
€3.76
16.09.24
€5.00
30.04.27
1.06%
18.09.24

Could be very worthwhile Investment >20% year
buy
Hims & Hers Health Inc.

Start price
Target price
Perf. (%)
€14.76
13.09.24
€18.04
13.09.25
-0.41%
18.09.24

buy
Viromed Medical AG

Start price
Target price
Perf. (%)
€2.12
13.09.24
-
13.09.25
-4.72%
18.09.24

buy
Stoke Therapeutics Inc

Start price
Target price
Perf. (%)
€14.50
11.09.24
€31.76
11.09.25
-5.52%
18.09.24

buy
Marinus Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€1.22
08.09.24
€4.00
31.05.27
10.66%
18.09.24

Could be very worthwhile Investment >20% year
buy
Pharvaris N.v.

Start price
Target price
Perf. (%)
€17.20
08.09.24
€21.00
30.06.27
2.91%
18.09.24

Could be very worthwhile Investment >20% year
buy
Newamsterdam Pharma Company Nv

Start price
Target price
Perf. (%)
€15.30
08.09.24
€20.00
30.06.27
-5.88%
13.09.24

Could be very worthwhile Investment >20% year
buy
Exagen Inc.

Start price
Target price
Perf. (%)
€2.80
08.09.24
€3.70
31.05.27
-12.86%
18.09.24

Could be very worthwhile Investment >20% year
buy
Chemometec As

Start price
Target price
Perf. (%)
€53.50
08.09.24
€70.00
31.03.27
5.23%
17.09.24

Could be very worthwhile Investment >20% year
buy
Adagene Inc.

Start price
Target price
Perf. (%)
€2.38
08.09.24
€3.20
31.03.27
32.77%
16.09.24

Could be very worthwhile Investment >20% year
buy
Spero Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.22
08.09.24
€2.10
31.03.27
-0.82%
18.09.24

Could be very worthwhile Investment >20% year